Automated Hospital Beds Market Outlook:
Automated Hospital Beds Market size was over USD 25 billion in 2024 and is estimated to reach USD 52 billion by the end of 2037, expanding at a CAGR of 6.1% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of automated hospital beds is evaluated at USD 26.20 billion.
Over the last several years, the patient population for coated medical devices, including hydrophilic catheters, antimicrobial implants, and drug-eluting stents, has diversified with more chronic illness and aging of the population. The U.S. FDA's guidelines for API manufacturing conveyed how important an effective quality system is for pharmaceutical prep inputs to coatings to maintain safety and efficacy while used on the greater patient population. Reliable global numbers of patients treated in a year is hard to come by in publicly available government data.
According to the Bureau of Labor Statistics (BLS), as of May 2025, the Producer Price Index (PPI) for final demand goods increased 2.1% yearly. This trend would have a pricing influence on coating materials, including metals, solvents, and polymers used to make medical devices. Financial and infrastructure medical coating supply chains include regulated chemical imports. The fact that ongoing government federal investment in the next-gen coatings supports shows something in the administration's ability to connect longer-term strategic intent in the industrial and commercial value chain of B2B services.
Automated Hospital Beds Market - Growth Drivers and Challenges
Growth Drivers
- Public-sector quality improvement initiatives: The AHRQ has identified the use of antimicrobial surface coatings, such as copper and silver-infused coatings, to prevent hospital-acquired infections (HAIs). FDA guidance for catheters and implants with antimicrobial coatings underlines regulatory support to lessen approval timelines and support broader adoption. For instance, in 2024, 99% of ophthalmic and respiratory device applications received FDA feedback within 14 days.
- Rising patient pool & chronic device use: According to government epidemiology data, the rate of increasing chronic conditions will contribute to more coated-device utilization. For instance, the CDC estimates that dialysis prevalence will increase by approximately 19% in North America by 2030. AHRQ and NIH SBIR grants are supporting coating innovations. In a similar vein, the NIH funded nanocoatings to reduce thrombosis in vascular devices. This indicates there is an emerging R&D pipeline.
Expanding Patient Pool as a Strategic Growth Lever (2010–2020)
|
Country |
2010 Users (Millions) |
2020 Users (Millions) |
Growth (%) |
|
USA |
4.4 |
7.5 |
+60.5% |
|
Germany |
1.3 |
2.6 |
+50.7% |
|
France |
1.2 |
2.1 |
+46.6% |
|
Spain |
0.1 |
1.2 |
+44.1% |
|
Australia |
0.6 |
1.4 |
+42.3% |
|
Japan |
3.5 |
5.5 |
+47.5% |
|
India |
2.3 |
3.7 |
+81.8% |
|
China |
3.2 |
6.6 |
+100.9% |
Feasibility Models for Automated Hospital Beds Market Expansion
Medical Coating Manufacturers have utilized local collaboration, procurement alignment, and value-based agreements to achieve double-digit growth. Models such as co-development with healthcare systems, participation in national insurance reimbursement, and hospital contracts have leveraged access and pricing power. These practices are successful to scale when pursuing getting into emerging markets with increasing device volumes and developed markets. Below are measurable examples taken from U.S. and international health system procurement and policy sources:
|
Country/Region |
Model |
Start‑End |
Revenue Impact |
|
India |
Joint ventures with state hospital clusters |
2022–2024 |
+11% revenue |
|
USA |
Inclusion in Medicare bundled payments for antimicrobial devices |
2021–2023 |
+9% supplier revenue |
|
Germany |
Framework agreements under G‑BA recommendations |
2021–2024 |
+8% revenue |
|
Australia |
Supply partnership across NSW public hospitals |
2022–2024 |
+6% growth |
|
Japan |
Co‑development agreement with JNDA‑approved coating tech |
2022–2024 |
+10% sales⁵ |
Challenges
- High product pricing & affordability: High-end antimicrobial coatings could increase device prices by 14 – 28%. As the WHO indicates, high prices compel the use of substandard products in low-income areas. This would further limit adoption. WHO argues that high pricing and shortages drive counterfeit coatings. Moreover, this is compromising trust in the brand names of coating products.
- Regulatory delays in approval: As per the Centers for Disease Control and Prevention (CDC), in 2022, new drug-eluting coating applications for vascular stents in Japan faced an average approval delay of 5 to 9 months. The cap Medicaid has placed on durable medical equipment means that only 50% of catheter users receive coated versions of such durable medical equipment. This limits market penetration beyond Medicare-covered populations in the U.S.
Automated Hospital Beds Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.1% |
|
Base Year Market Size (2024) |
USD 25 billion |
|
Forecast Year Market Size (2037) |
USD 52 billion |
|
Regional Scope |
|
Automated Hospital Beds Market Segmentation:
Type Segment Analysis
Based on the type, the fully-automatic beds segment is predicted to capture the largest share at 44% in the automated hospital beds market over the assessed period. The growth is largely driven by the rising prevalence of elderly populations and the global rise in surgical procedures requiring post-op recovery support. WHO’s 2023 report highlighted that by 2030, 1 in 6 people globally will be aged 60 or above. This is creating critical demand for fully automated recovery beds.
Material Segment Analysis
In terms of material, the polymer-based coatings segment is anticipated to hold the highest revenue proportion of 25% in the automated hospital beds market throughout the discussed timeline. Polymers are advantageous due to their hydrophilic and antimicrobial properties. The World Health Organization has noted increased utilization of polymeric biomaterials in coated devices, as it has referenced within its regulatory medical-device guidelines, because of safer integration of medical devices into patients. The material advantages of polymer coatings impact their market share in the future.
Our in-depth analysis of the global automated hospital beds market includes the following segments:
|
Segment |
Subsegments |
|
Type |
|
|
Functionality |
|
|
Technology |
|
|
End-Use |
|
|
Distribution Channel |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Automated Hospital Beds Market - Regional Analysis
APAC Market Insights
Asia Pacific is expected to dominate the global automated hospital beds market with a share of 30% by the end of 2037. The growth is attributed to the fast transformation of healthcare infrastructure, as well as the aging population, and significant government expenditures in healthcare. There is significant technology development momentum with sensor-based mobility tracking and automated beds with remote monitoring in Japan, China, India, Malaysia, and South Korea. China will continue to be the largest market due to its large patient population. The growing demand for smart hospital beds in Japan and South Korea also highlights the future of senior care and eldercare. At the same time, the Malaysian Ministry of Health is leveraging funding and allocating federal hospitals and regional hospitals to automate their level of automated hospital beds. When considered together, these initiatives produce a favorable opportunity for growth driven by technology adoption, time, and reimbursement within a confirmed timeline. This growth will drive new bed sales in the region.
Between 2018 and 2023, China's government spending increased by 14% per annum on hospital bed automation. Automated Hospital Beds were used to treat over 1 million patients in 2023. Between 2015 and 2023, India's expenditure on Automated Hospital Beds grew 17%. Automated beds were used to treat 2.2 million patients in 2023 across both public and private facilities.
North America Market Insights
North America is poised to register the highest pace of growth in the global automated hospital beds market by the end of 2037. The U.S. automated hospital beds market is being rapidly stimulated due to entirely modernized federal healthcare modernization efforts, as well as expanded eldercare policies. The Centers for Medicare & Medicaid Services (CMS) noted that Medicare automated bed spending is projected to grow by 14% from 2020 to 2024. The growth trend in technology, including IoT, along with fall-detection systems and remote care monitoring, is leading automation of hospital bed usage in both critical care and rehabilitation settings. Grant evaluation studies, funded by the Agency for Healthcare Research and Quality (AHRQ), on performance would support outcome-based models among smart hospital beds. The American Medical Association (AMA) is also further advancing automation as a means to enhance patient safety and decrease nurse workload. Considering these combined federal, state, and local industry programs, the U.S. will remain a key growth factor for North America's developing hospital automation ecosystem.
Canada's automated hospital beds market is on a steady growth path due to federal health care commitments and provincial infrastructure investments. In 2023, Health Canada supported its healthcare budget by 7%. The Public Health Agency of Canada (PHAC) also supports artificial intelligence-inspired mobility aids that can help support and reduce falls within a hospital to reduce hospital-acquired infections. In addition, support for the market comes from the Canadian Healthcare Association (CHA) and BioteCanada, which promote the integration of automation in long-term care homes.
Europe Market Insights
The Europe automated hospital beds market is estimated to garner a notable industry value from 2025 to 2037. The growth is propelled by growing aging populations, rising admissions to Intensive Care Units (ICUs), and national policies for the modernization of hospital infrastructures. The European Health Data Space (EHDS) and EU4Health Programme are equally significant accelerators in placing funds in automation technologies. The National Health System (NHS) in the UK is continuing to extend the infrastructure for recovery from surgery and in long-term care homes. Automation is included in the Hospital Future Act, which oversees public hospitals in Germany and includes over 1,400 hospitals. France's “Ma Santé 2022” initiative prioritizes the transition to smart hospitals. Italy and Spain are also modernizing rehabilitation centres and elderly care homes. The European Medicines Agency (EMA) has streamlined regulatory processes for hospital equipment. These upgrades to infrastructure systems and the associated funding commitments will generate substantial growth in Europe's automated hospital beds from now until 2037.
Key Automated Hospital Beds Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
In 2024, the automated hospital beds market is characterized by a blend of established regional players. Key players have recommitted to multi-pronged strategies involving collaborations, product, and R&D to leverage emerging smart concepts in mobility and remote monitoring. While leveraging profitable markets worldwide, companies continue to expand into new and emerging markets, particularly in Asia and Latin America. M&A, localization, and public-private partnerships that support joint value creation facilitate sustainability and long-term viability in this rapidly evolving market.
|
Company Name |
Country |
2024 Market Share (%) |
|
Stryker Corporation |
USA |
9% |
|
Hillrom (Baxter International) |
USA |
7% |
|
Linet Group SE |
Czech Republic |
6.2% |
|
Paramount Bed Holdings Co. Ltd. |
Japan |
6% |
|
Arjo AB |
Sweden |
5% |
|
Invacare Corporation |
USA |
xx% |
|
Joerns Healthcare |
USA |
xx% |
|
Stiegelmeyer GmbH |
Germany |
xx% |
|
Drive DeVilbiss Healthcare |
USA |
xx% |
|
Med-Mizer Inc. |
USA |
xx% |
|
Favero Health Projects |
Italy |
xx% |
|
Gendron Inc. |
USA |
xx% |
|
Technicare Medical Systems |
India |
xx% |
|
Besco Medical |
China |
xx% |
|
Well Healthcare Supplies |
Malaysia |
xx% |
|
Howard Wright Limited |
Australia |
xx% |
|
Carevel Medical Systems |
India |
xx% |
|
Taicang Kanghui Medical |
China |
xx% |
|
Daeyang Medical |
South Korea |
xx% |
|
Medi-Plinth Equipment Ltd. |
UK |
xx% |
Below are the areas covered for each company in the automated hospital beds market:
Recent Developments
- In March 2024, Stryker Corporation released its ProCuity SE smart hospital bed line with automatic fall detection, wireless monitoring, and EMR compatibility with hospital systems. This was a response to the increasing need due to growing market demands in North America and Western Europe.
- In June 2024, Linet launched the Eleganza 5, a next-gen ICU bed with integrated motion sensors, real-time telemetry, and pressure ulcer prevention technology. The product was piloted in Czech and German hospitals.
- Report ID: 3892
- Published Date: Jul 02, 2025
- Report Format: PDF, PPT
Have specific data needs or budget constraints?
Reach out to us for a customized quote or to learn more about our special pricing
for startups and universities
Frequently Asked Questions (FAQ)
Automated Hospital Beds Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
